Evidence map›Paper›PMID 30679491›Full record

ArticleScientific reports2019

TaME-seq: An efficient sequencing approach for characterisation of HPV genomic variability and chromosomal integration.

Sonja Lagström, Sinan Uğur Umu, Maija Lepistö, Pekka Ellonen, Roger Meisal, Irene Kraus Christiansen, Ole Herman Ambur, Trine B Rounge

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sonja LagströmDepartment of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway.
Sinan Uğur UmuDepartment of Research, Cancer Registry of Norway, Oslo, Norway.ORCID 0000-0001-8081-7819
Maija LepistöInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Pekka EllonenInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Roger MeisalDepartment of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway.ORCID 0000-0003-1002-3655
Irene Kraus ChristiansenDepartment of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway.
Ole Herman AmburFaculty of Health Sciences, OsloMet - Oslo Metropolitan University, Oslo, Norway.
Trine B RoungeDepartment of Research, Cancer Registry of Norway, Oslo, Norway. trine.rounge@kreftregisteret.no.ORCID 0000-0003-2677-2722

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HPV genomic variability and chromosomal integration are important in the HPV-induced carcinogenic process. To uncover these genomic events in an HPV infection, we have developed an innovative and cost-effective sequencing approach named TaME-seq (tagmentation-assisted multiplex PCR enrichment sequencing). TaME-seq combines tagmentation and multiplex PCR enrichment for simultaneous analysis of HPV variation and chromosomal integration, and it can also be adapted to other viruses. For method validation, cell lines (n = 4), plasmids (n = 3), and HPV16, 18, 31, 33 and 45 positive clinical samples (n = 21) were analysed. Our results showed deep HPV genome-wide sequencing coverage. Chromosomal integration breakpoints and large deletions were identified in HPV positive cell lines and in one clinical sample. HPV genomic variability was observed in all samples allowing identification of low frequency variants. In contrast to other approaches, TaME-seq proved to be highly efficient in HPV target enrichment, leading to reduced sequencing costs. Comprehensive studies on HPV intra-host variability generated during a persistent infection will improve our understanding of viral carcinogenesis. Efficient identification of both HPV variability and integration sites will be important for the study of HPV evolution and adaptability and may be an important tool for use in cervical cancer diagnostics.

Indexed as

AlphapapillomavirusChromosome BreakpointsFemaleGenetic VariationGenome, ViralHuman papillomavirus 16Human papillomavirus 18HumansMultiplex Polymerase Chain ReactionPapillomavirus InfectionsUterine Cervical NeoplasmsVirus Integration

Identifiers

PMID30679491
PMCPMC6345795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.